Watchmaker Genomics

Boulder, COEst. 2019Genomics & Life-Science Tools

Visit website LinkedIn

Founded

2019

Stage

Series A

Team size

100-300 employees

Sector

Health & Life Sciences

About

Watchmaker Genomics develops high-performance enzymes for next-generation sequencing and genomic research, using a computational design and directed evolution platform. Co-founded by Trey Foskett (formerly Kapa Biosystems, sold to Roche for $500M), the company is an Endeavor Colorado portfolio company.

Funding

Last roundSeries A

Amount raised$40M

Funding detail is compiled from public sources and may lag recent activity.

An Endeavor Colorado company

Watchmaker Genomics is part of the Endeavor Colorado portfolio, which means its founders have access to our global network of mentors, investors and operators.

See the full portfolio